The authors thank T. Yamamoto and Y. Mori for their assistance in the morphologic experiments. This work was supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (18K06871 to M.O.K. and 17K08536 to H.M.).

All animal experiments conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and were approved by the institutional Review Board of the Shiga University of Medical Science Animal Care and Use Committee (approved No. 2019-3-7). The methods were carried out in accordance with approved guidelines.
1. Instruments and solution
NOTE: An outline of the experimental procedure is illustrated in a flow diagram (Supplementary Figure 1). An infusion pump (or syringe pump) should be used for the antegrade perfusion of the heart with a one-way flow. A peristaltic pump that creates a pulsating flow is not recommended.
<ol>
	<li>Before the experimental
	<ol>
		<li>Mark the injection needle at a site approximately 3 mm from the tip with nail polish. After allowing it the air dry, keep it in the container at room temperature. A red or bright color is desirable to confirm the depth of insertion into the myocardium during perfusion.</li>
		<li>Make the heart stand by cutting the lids off of 1.5-, 0.5- and 0.2-mL sample tubes and attaching the lids to the bottom of a 60-mm culture dish with double-sided tape or adhesive. Fixation of three different-sized lids in one dish makes it possible to choose the appropriate one according to the size of the mouse heart. This heart stand can be reused after washing.</li>
		<li>Make stock solution as shown in Table 1. Store the stock solutions at 4 &#176;C.</li>
	</ol>
	</li>
	<li>On the experiment day 
	NOTE: Cell isolation buffer (CIB) contains (in mM) 130 NaCl, 5.4 KCl, 0.5 MgCl2, 0.33 NaH2PO4, 22 glucose, 40 units/mL insulin and 25 HEPES (pH adjusted to 7.4 with NaOH); and Tyrode solution contains (in mM) 140 NaCl, 5.4 KCl, 1.8 CaCl2, 0.5 MgCl2, 0.33 NaH2PO4, 5.5 glucose and 5.0 HEPES (pH adjusted to 7.4 with NaOH).
	<ol>
		<li>Prepare the CIB. Warm 160 mL of distilled water (DW) using a microwave to around 32 &#176;C and then add 20 mL of 10X CIB. After the addition of 0.79 g glucose and 10 &#181;L of insulin solution, adjust the pH using 1 M NaOH and bring to 200 mL with DW.</li>
		<li>Prepare the enzyme mix solution (enzyme mix). Add 30 mg of collagenase, 1.8 mg of trypsin, 1.8 mg of protease and 90 &#181;L of 100 mM CaCl2 stock solution to 30 mL of CIB (final Ca2+ concentration is 0.3 mM), mix, and keep it on ice. In mice &#60;4 weeks old, reduce trypsin and protease to 0.9 mg10. Warm at 37 &#176;C in a water bath before use.</li>
		<li>Prepare the CIB-Ca2+-BSA solution. Add 30 mg BSA and 90 &#181;L of 100 mM CaCl2 stock solution to 15 mL of CIB (final Ca2+ concentration is 1.2 mM), mix, filter through a 20-&#181;m filter, and keep it on ice.</li>
		<li>Prepare the CIB-EGTA solution. After making the solutions described in steps 1.2.2 and 1.2.3, add 400 mM EGTA stock solution to the remaining CIB at a 1:1000 dilution (final EGTA concentration is 0.4 mM), and mix. Fill the 35-mm culture dish and heart stand dish with CIB-EGTA and keep them on ice.
		<ol>
			<li>Pour approximately 20 mL of CIB-EGTA into a 30-mL glass beaker and stand a plastic transfer pipette in the beaker, keeping it on ice.</li>
		</ol>
		</li>
		<li>Prepare Tyrode solution. Add 100 mL of 10X&#160;Tyrode to 800 mL of DW and warm it using a microwave to around 32 &#176;C. After adding 0.99 g of glucose and 1.8 mL of 1 M CaCl2, adjust the pH using 1 M NaOH and bring to 1000 mL with DW.</li>
		<li>Prepare the cell resuspension solution. Add 30 mg of BSA and 300 &#181;L of 50X&#160;antibiotics to 15 mL of Tyrode solution.</li>
		<li>Prepare syringes. Fill the 20-mL syringe connected with the flexible extension tube and the marked injection needle with CIB-EGTA. Fill the 30-mL syringe with the warmed enzyme mix. Hold them both at 37 &#176;C until just before use.</li>
		<li>Prepare the perfusion plate. Prewarm the heater mat under a stereoscopic microscope. Place the perfusion plate (lid of a multi-well culture plate) on the prewarmed heater mat. Prewarm the vascular clamp by placing it in the perfusion plate until use. Place the 60-mm culture dish for pipetting and the cell strainer on the prewarmed heater mat as well.</li>
	</ol>
	</li>
</ol>
2. Antegrade perfusion of the mouse heart
NOTE: The plastic transfer pipette used for sucking the heart should be soft and not be sharply tapered towards the tip. Choose a small vascular clamp with serration. The recommended instruments are listed in the Table of Materials.
<ol>
	<li>Excision of the mouse heart and clamping the aorta 
	NOTE: The adult mice (&#62;8 weeks old) should be euthanized by an overdose of sodium pentobarbital (&#62;300 mg/kg, intraperitoneal [i.p.] injection) with heparin (8000 unit/kg).
	<ol>
		<li>Excise the mouse heart quickly by sucking.
		<ol>
			<li>Open the thoracic cavity quickly to expose the heart. Cut the plastic transfer pipette, the tip of which is approximately the same size as, or slightly smaller than, the exposed heart (usually at a site approximately 1 cm from the 0.5-mL mark towards the tip, but it depends on the heart size).</li>
			<li>Suck the heart into the pipette, raise the pipette to create enough space to insert scissors, and excise the heart with curved scissors from the dorsal side, avoiding damaging the atria.</li>
			<li>Immediately transfer the excised heart to the 30-mL glass beaker containing ice-chilled CIB-EGTA to stop the contraction. This procedure usually takes &#60;1 min.</li>
		</ol>
		</li>
		<li>Cleaning around the aorta
		<ol>
			<li>Transfer the heart to a 35-mm culture dish filled with ice-chilled CIB-EGTA and remove the lung and other visible tissues, and then transfer the roughly cleaned heart to the heart stand filled with chilled CIB-EGTA and place it with the apex down.</li>
			<li>Under the stereoscopic microscope, remove the fat and connective tissues to clean around the aorta. If the length of the cut aorta is too long including the brachiocephalic artery, the left common carotid artery or the left subclavian artery, cut off the aorta just under the brachiocephalic artery to shorten it in order to proceed to the next step. This procedure usually takes approximately 4 min.</li>
		</ol>
		</li>
		<li>Clamping the aorta and placing the clamped heart on the perfusion plate
		<ol>
			<li>Under the microscope, place the heart in the heart stand. The operator should face the anterior surface of the heart, pick up the end of the aorta with tweezers, and clamp the aorta near the atria with a small vascular clamp while gently pushing down on the aorta a bit.</li>
			<li>Place the clamped heart on the perfusion plate with the anterior side up, and then cover it with a few drops of CIB-EGTA to keep it from drying out. This procedure usually takes &#60;20 s.</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Antegrade perfusion of the heart 
	NOTE: First, perfuse the heart with CIB-EGTA to discharge blood and prevent clotting.
	<ol>
		<li>Insert the injection needle and start perfusion to discharge blood
		<ol>
			<li>Set the 20-mL syringe filled with prewarmed CIB-EGTA connected to the flexible extension tube and a marked injection needle on the infusion pump. Start the pump at a slow rate of 0.5 mL/min to carefully fill the needle and tube with CIB-EGTA and be sure to prevent any air from entering the tube.</li>
			<li>Place the injection needle on the perfusion plate with the shorter side of the diagonal shape in front. Slide the needle towards the apex of the heart until it is touching it, and then carefully insert the needle near the apex of the left ventricle into the ventricular chamber without twisting. Do not detach the needle from the plate while performing insertion.</li>
			<li>Watch the red mark to estimate the depth of the needle insertion. When the needle insertion is completed, blood flowing from the coronary artery should start to be discharged.</li>
			<li>Fix the injection needle on the plate with tape, and increase the pump speed to 1 mL/min. This procedure usually takes approximately 30 s. If the heart is perfused successfully, the flow of the CIB-EGTA in the capillary just under the epicardium can be seen under the microscope.</li>
		</ol>
		</li>
		<li>Perfusion the heart with enzyme mix 
		NOTE: During enzymatic perfusion, the depth of the inserted needle can be monitored by checking the red mark on the needle.
		<ol>
			<li>After perfusing 2-3 mL of CIB-EGTA to completely discharge blood from the coronary artery, change the perfusate to enzyme mix. Avoid allowing air bubbles to enter the tube. Check the flow of the enzyme mix, and ensure that the injection needle has not come out by checking the position of the red mark.</li>
			<li>After 1-2 mL has been perfused, increase the pump speed to 1.5 mL/min. Remove the accumulated perfusate containing blood that has flowed out of the heart with a pipette from time to time. 
			NOTE: Over time, the myocardial wall will become translucent in some places and appear mottled, which is a sign of digestion of the extracellular matrix following successful perfusion. Another sign is the restarting of atrial beating caused by the presence of Ca2+ in the enzyme mix.</li>
			<li>Stop perfusion when the total volume of the enzyme mix perfused is 10 mL.</li>
		</ol>
		</li>
	</ol>
	</li>
</ol>
3. Isolation of individual heart cells
<ol>
	<li>Dissociating heart cells
	<ol>
		<li>After perfusion with the enzyme mix, transfer 10 mL of the enzyme mix remaining in the syringe to a 60-mm culture dish placed on the heater mat and add 20 mg of BSA (0.2% BSA in enzyme mix). The dropped BSA powder should dissolve immediately by gently swirling with a hand. Remove the injection needle and the vascular clamp from the heart.</li>
		<li>Separate the ventricles and atria and transfer each into the enzyme mix supplemented with 0.2% BSA on the heater mat.</li>
	</ol>
	</li>
	<li>Isolation of ventricular myocytes
	<ol>
		<li>Grab the epicardium with two tweezers, and gently tear and pull the ventricles from side to side in the enzyme mix supplemented with 0.2% BSA into small pieces. Disperse the cells with gentle pipetting (approximately 30 times).</li>
		<li>Filter the undigested debris through a 100-&#181;m mesh cell strainer, and transfer the filtrate to a 15-mL centrifuge tube for centrifugation at 50 &#215; g for 3 min. Resuspend the pelleted cardiomyocytes in prewarmed CIB-Ca2+-BSA solution, incubate it for 5 min at 37 &#176;C, and then centrifuge it at 14 &#215; g for 3 min.</li>
		<li>Resuspend the final precipitated cardiomyocytes in cell resuspension solution (composition is listed in Table 2) and hold it at 37 &#176;C.</li>
	</ol>
	</li>
	<li>Isolation of atrial myocytes
	<ol>
		<li>During the final centrifugation for the ventricular myocyte fraction in step 3.2, start isolating the atrial myocytes. Transfer the atria, stored as in step 3.1, to the prewarmed CIB-Ca2+-BSA solution, tear it into pieces and dissociate the cells by pipetting with pipette tip at 10 &#181;L on the heater mat.</li>
		<li>Centrifuge the cell mixture at 14 &#215; g for 3 min and resuspend the pelleted atrial cells with cell resuspension solution.</li>
	</ol>
	</li>
	<li>Isolation and culture of cardiac fibroblasts
	<ol>
		<li>Transfer the supernatant from the first centrifugation in step 3.2 to another 15-mL centrifuge tube, and centrifuge at 190 &#215; g for 5 min. Wash the precipitated cells twice with centrifugation in Dulbecco&#39;s Modified Eagle Medium (DMEM), and then suspend the cells with DMEM supplemented with 10% fetal bovine albumin (FBS) and antibiotics.</li>
		<li>Plate the final cell fraction in a culture flask (25 cm2) and allow the cells to adhere to the bottom of the flask in a humidified atmosphere of 95% air and 5% CO2. After 90 min incubation, discard the unattached cells, and add fresh culture medium. Cells should near confluency after approximately 4 days, at which point they should be amplified by trypsinization and seeded into new culture dishes.</li>
	</ol>
	</li>
</ol>
4. Harvesting proteins from atria and ventricles
<ol>
	<li>After perfusion, separate the atria and ventricles, and homogenize them in lysis buffer at a ratio of 10 mg of tissue weight to 100 &#181;L of buffer using a small grinder in a 1.5-mL sample tube.</li>
	<li>Keep the homogenate in ice for 40 min with vortex mixing every 10 min to extract proteins, and then centrifuge the tube at 15000 &#215; g for 20 min at 4 &#176;C. Store the supernatant fraction at -80 &#176;C as a protein sample.</li>
</ol>
5. Immunostaining of isolated heart cells
NOTE: Immobilization of non-adherent cardiomyocytes to the bottom of the cell imaging dish using biological glue is necessary.
<ol>
	<li>Adhesion of isolated cardiomyocytes to a glass-bottom culture dish
	<ol>
		<li>Before starting cell isolation, coat the glass-bottom culture dish with biological glue (e.g., Cell-Tak) according to the manufacturer&#39;s instruction, rinse with DW, and air-dry at room temperature.</li>
		<li>After resuspension of the isolated cardiomyocytes in CIB-Ca2+-BSA solution, drop the cell suspension on the bottom of the glue-coated dishes, and incubate for 20 min at room temperature without agitation.</li>
	</ol>
	</li>
	<li>Immunostaining
	<ol>
		<li>Plate the isolated cardiomyocytes on a glass-bottom dish precoated with biological glue and keep it at room temperature for 40 min to allow the cells to adhere to the dish. Culture cardiac fibroblasts in bottom-glass culture dishes.</li>
		<li>Rinse cells with phosphate-buffered saline (PBS), and fix them with 4% paraformaldehyde (PFA) for 5 min with shaking. Wash the fixed cells with PBS for 10 min three times, and incubate them in blocking-permeabilization solution for 60 min at room temperature with shaking.</li>
		<li>Probe cells with primary antibody diluted in blocking-permeabilization solution for 60 min at room temperature or overnight at 4 &#176;C. Wash the cells with PBS for 10 min three times, and incubate then with fluorescence-labeled secondary antibody for 60 min at room temperature.</li>
		<li>After washing them three times with PBS for 10 min, stain the nuclei with DAPI (1:10000 dilution in PBS). Analyze the fluorescent signals using a confocal laser scanning microscope.</li>
	</ol>
	</li>
</ol>
6. Whole-cell patch clamp recordings
<ol>
	<li>Fabricate the patch electrodes from a glass capillaries using a horizontal microelectrode puller. The resistance of the electrode ranged from 2 to 4 M&#937; when filled with a K+-rich pipette solution (Table 2). Transfer an aliquot of isolated cardiomyocytes to a recording chamber mounted on the stage of an inverted microscope superfused with Tyrode at a rate of 1 mL/min&#160;at 36-37 &#176;C.</li>
	<li>Record action potentials using the perforated patch-clamp method with K+-rich pipette solution containing 30 mg/mL amphotericin B by applying current pulses of 5-10 ms in duration at a rate of 1 Hz via the patch electrode.</li>
</ol>
7. Western blot analyses
<ol>
	<li>In this study, perform a Western blot analysis of small-molecular-weight proteins, such as atrial marker atrial natriuretic peptide (ANP).</li>
	<li>Dissolve the protein sample in the final concentration of 1X Sample buffer, 2% 2&#39; mercaptoethanol, and denature the proteins for 60 min at 37 &#176;C. Load 20 &#181;g of protein into each well, and perform electrophoresis in running buffer with 20 mA per gel for 120 min.</li>
	<li>Transfer the protein to a PVDF membrane in transfer buffer at 10 V for 40 min. Wash the transferred membrane twice with TBST for 5 min, then block with 5 % skim milk in TBST for 60 min at room temperature, and probe with the primary antibody dissolved in TBST overnight at 4 &#176;C.</li>
	<li>Wash the membrane 5 times with TBST for 7 min, and incubate it with the secondary antibody diluted in TBST for 120 min at room temperature.</li>
	<li>After washing the membrane 5 times with TBST for 7 min, visualize the signals with a chemi-luminescence assay and analyze them with a lumino-image analyzer.</li>
</ol>

<ol>
	<li>Langendorff, O. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Untersuchungen+am+&#252;berlebenden+S&#228;ugethierherzen.">Untersuchungen am &#252;berlebenden S&#228;ugethierherzen.</a> Pfl&#252;gers Archiv: European Journal of Physiology. 61, 291-332 (1898).</li><li>Berry, M. N., Friend, D. S., Scheuer, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Morphology+and+metabolism+of+intact+muscle+cells+isolated+from+adult+rat+heart.">Morphology and metabolism of intact muscle cells isolated from adult rat heart.</a> Circulation Research. 26 (6), 679-687 (1970).</li><li>Powell, T., Terrar, D. A., Twist, V. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Electrical+properties+of+individual+cells+isolated+from+adult+rat+ventricular+myocardium.">Electrical properties of individual cells isolated from adult rat ventricular myocardium.</a> Journal of Physiology. 302, 131-153 (1980).</li><li>Joshi-Mukherjee, R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Structural+and+functional+plasticity+in+long-term+cultures+of+adult+ventricular+myocytes.">Structural and functional plasticity in long-term cultures of adult ventricular myocytes.</a> Journal of Molecular and Cellular Cardiology. 65, 76-87 (2013).</li><li>Benndorf, K., Boldt, W., Nilius, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Sodium+current+in+single+myocardial+mouse+cells.">Sodium current in single myocardial mouse cells.</a> Pfl&#252;gers Archiv: European Journal of Physiology. 404 (2), 190-196 (1985).</li><li>Zhou, Y. Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Culture+and+adenoviral+infection+of+adult+mouse+cardiac+myocytes:+methods+for+cellular+genetic+physiology.">Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology.</a> American Journal of Physiology-Heart and Circulatory Physiology. 279 (1), 429-436 (2000).</li><li>Shioya, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+simple+technique+for+isolating+healthy+heart+cells+from+mouse+models.">A simple technique for isolating healthy heart cells from mouse models.</a> Journal of Physiological Sciences. 57 (6), 327-335 (2007).</li><li>Fiset, C., Clark, R. B., Larsen, T. S., Giles, W. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+rapidly+activating+sustained+K++current+modulates+repolarization+and+excitation-contraction+coupling+in+adult+mouse+ventricle.">A rapidly activating sustained K+ current modulates repolarization and excitation-contraction coupling in adult mouse ventricle.</a> Journal of Physiology. 504, 557-563 (1997).</li><li>Ackers-Johnson, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+Simplified,+Langendorff-Free+Method+for+Concomitant+Isolation+of+Viable+Cardiac+Myocytes+and+Nonmyocytes+From+the+Adult+Mouse+Heart.">A Simplified, Langendorff-Free Method for Concomitant Isolation of Viable Cardiac Myocytes and Nonmyocytes From the Adult Mouse Heart.</a> Circulation Research. 119 (8), 909-920 (2016).</li><li>Omatsu-Kanbe, M., Yoshioka, K., Fukunaga, R., Sagawa, H., Matsuura, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+simple+antegrade+perfusion+method+for+isolating+viable+single+cardiomyocytes+from+neonatal+to+aged+mice.">A simple antegrade perfusion method for isolating viable single cardiomyocytes from neonatal to aged mice.</a> Physiological Reports. 6 (9), 13688 (2018).</li><li>Sambrano, G. R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Navigating+the+signalling+network+in+mouse+cardiac+myocytes.">Navigating the signalling network in mouse cardiac myocytes.</a> Nature. 420 (6916), 712-714 (2002).</li><li>Limana, F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=bcl-2+overexpression+promotes+myocyte+proliferation.">bcl-2 overexpression promotes myocyte proliferation.</a> Proceedings of the National Academy of Sciences of the United States of America. 99 (9), 6257-6262 (2002).</li><li>Santiago, J. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cardiac+fibroblast+to+myofibroblast+differentiation+in+vivo+and+in+vitro:+expression+of+focal+adhesion+components+in+neonatal+and+adult+rat+ventricular+myofibroblasts.">Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts.</a> Developmental Dynamics. 239 (6), 1573-1584 (2010).</li><li>Chistiakov, D. A., Orekhov, A. N., Bobryshev, Y. V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+role+of+cardiac+fibroblasts+in+post-myocardial+heart+tissue+repair.">The role of cardiac fibroblasts in post-myocardial heart tissue repair.</a> Experimental and Molecular Pathology. 101 (2), 231-240 (2016).</li><li>Omatsu-Kanbe, M., Matsuura, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+novel+type+of+self-beating+cardiomyocytes+in+adult+mouse+ventricles.">A novel type of self-beating cardiomyocytes in adult mouse ventricles.</a> Biochemical and Biophysical Research Communications. 381 (3), 361-366 (2009).</li><li>Shan, D., Marchase, R. B., Chatham, J. C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Overexpression+of+TRPC3+increases+apoptosis+but+not+necrosis+in+response+to+ischemia-reperfusion+in+adult+mouse+cardiomyocytes.">Overexpression of TRPC3 increases apoptosis but not necrosis in response to ischemia-reperfusion in adult mouse cardiomyocytes.</a> American Journal of Physiology. 294 (3), 833-841 (2008).</li><li>Nakamura, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Presence+and+functional+role+of+the+rapidly+activating+delayed+rectifier+K(+)+current+in+left+and+right+atria+of+adult+mice.">Presence and functional role of the rapidly activating delayed rectifier K(+) current in left and right atria of adult mice.</a> European Journal of Pharmacology. 649 (1-3), 14-22 (2010).</li><li>Milgroom, A., Ralston, E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Clearing+skeletal+muscle+with+CLARITY+for+light+microscopy+imaging.">Clearing skeletal muscle with CLARITY for light microscopy imaging.</a> Cell Biology International. 40 (4), 478-483 (2016).</li></ol>

The authors have nothing to disclose.

Since the heart is highly susceptible to ischemia, the time taken to excise the heart and immerse it in ice-cold CIB-EGTA to stop contraction should be kept short as possible (&#60;1 min). This is the first critical step of this method. The second critical step concerns the direction of the heart. The particular orientation of the excised heart in step 2.1.2 makes it easier to see and remove the fat and connective tissues around the aorta. After cleaning around the aorta, place the clamped heart with anterior surface side up on the perfusion plate. The final critical step involves the insertion of the injection needle. When advancing the needle towards the heart, the injection needle should not be detached from the perfusion plate in order to maintain a constant distance from the plate. The position of the insertion is near the apex of the left ventricle. Insert the needle carefully without twisting, since such twisting may enlarge the hole. The depth of the insertion of the needle can be estimated by watching the red mark. If the needle is inserted too deep, the tip may pierce through the ventricular septum and enter the right ventricle or though the mitral valve and enter the left atrium. After confirming the disappearance of the blood from the coronary artery, the needle should be fixed with tape to the perfusion plate.
A longer aorta length makes it difficult to clamp the aorta at the right position. If the clamp is too distant from the atria, the heart may rotate after perfusate infusion. To prevent this, cut off the aorta just under the brachiocephalic artery to shorten the aorta before clamping.
If the blood does not begin to discharge after perfusion at an initial speed of 0.5 mL/min, increase the speed to 1 mL/min. If that does not help, the injection needle may be positioned incorrectly, such as in the right ventricle, ventricular septum or left myocardial wall. In such a case, remove the needle immediately and try to re-insert it near the apex of the left ventricle. When inserting the needle several times, digested cells may flow out from the opened holes. Note that this does not usually seriously affect the cell isolation.
The operators can monitor the entire process of antegrade perfusion of the heart using a stereoscopic microscope to observe the changes in color and transparency and restarting of the beating of the atria along with the digestion. A total of 10 mL of enzyme mix should be the maximum required, even for an old heart. In younger hearts (5-7 weeks old), we reduce the volume to 9 mL, which is similar to the approach via retrograde perfusion with the same enzyme mix.
The supernatant at the final centrifugation contains debris, blood cells, and non-myocytes whereas, the pellet contains mainly cardiomyocytes and contaminating non-myocytes, such as fibroblasts and endothelial cells. To purify the cardiomyocytes, more steps are needed. In general, the pellet should be resuspended in the appropriate cell culture medium and preplated for 2 h at 37&#176;C on a tissue cell culture dish, and then gently remove the cardiomyocytes by pipetting and preplating for culture.
The enzyme mix contains a low concentration of Ca2+ (0.3 mM). We therefore incubate digested cells in CIB-Ca2+-BSA (1.2 mM Ca2+) before the final resuspension with the cell resuspension solution (1.8 mM Ca2+), and the gradual increase in Ca2+ avoids causing cell damage7. As long as the isolated cardiomyocytes are intact (quiescent cells with no contraction) this Ca2+-adapting procedure does not affect cell viability in mice. As the damaged cells are dying during this incubation, we consequently obtain a healthy cell group. Similarly, isolated intact atrial myocytes (quiescent cells without irregular contraction) can be stored in the same cell resuspension solution. However, the atrial myocytes tend to be more delicate to be stored compare to the ventricular myocytes.
In the laboratory, this isolation method is almost always successful unless the needle insertion into the left ventricle fails. We have also succeeded in isolating cells from the hypertrophied heart prepared by surgical transverse aortic constriction. However, in aged mice, which often have small myocardial infarctions, perfusion ceases in some places, resulting in incomplete digestion and thus a low yield (Figure 1C), similar to the Langendorff-based retrograde method. In such cases, the distorted shape of the heart can be observed even at the start of perfusion.
This antegrade perfusion method is useful for isolating heart cells from mice of various ages but not larger animals, such as rabbits and guinea pigs. It may be possible to apply this method to neonatal or juvenile rats before weaning.
One of the advantages of this antegrade perfusion method is that it decreases the technical obstacles associated with using the Langendorff-based retrograde perfusion method for small mouse hearts. The time required for perfusion is approximately 7 min with 10 mL of the enzymes, this short digestion period increases the viability of the cells. In addition, it enables perfusion to be performed through the coronary circulation of the heart, even after the aortic valves have been digested. Isolation of atrial myocytes usually requires Langendorff-based retrograde perfusion and further incubation with enzymes17. This antegrade perfusion approach, however, can deeply perfuse the tissue with the enzyme to isolate atrial myocytes.
In experiments using multiple mice, the Langendorff apparatus should be cleaned before perfusing the next heart. However, in the present antegrade method, as long as desired number of instrument sets (e.g., syringes needles and perfusion plates) are prepared in advance, perfusion can be performed continuously.
We herein report the basic methodology of the antegrade perfusion of the mouse heart using the same solutions as the Langendorff-based retrograde perfusion method with no additional chemicals. The composition of the perfusate can be changed to suit the purpose of the experiment, such as using a detergent containing EGTA instead of the enzymes to make a decellularized heart18.

Generally, the first step of the single cell isolation of dissected tissue involves mincing the tissue into small pieces, followed by the digestion of the connective tissue and extracellular matrix with enzymes. However, cardiomyocytes cannot be isolated with such a chopping method, as enrichment with extracellular matrix components, including collagen and elastin fibers, makes the myocardium too tough to mince, and the cardiomyocytes are highly sensitive to hypoxia and other changes in the microenvironment. Thus, using the Langendorff-based retrograde perfusion system1, a method of digesting the extracellular matrix with enzymes has been developed to isolate individual cardiomyocytes from the heart2,3,4.
In mouse models, Langendorff-based retrograde perfusion of the heart with enzymes is also used for the isolation of individual cardiomyocytes5,6,7,8.&#160;However, the cannulation of the small and thin mouse aorta and its mounting on the Langendorff apparatus to perform retrograde perfusion requires a high degree of skill, since the diameter of the aorta in the adult heart is approximately 1.2 mm. Furthermore, it takes time to perform multiple experiments as the Langendorff apparatus should be cleaned before perfusing the next heart.
As an alternative to retrograde perfusion, a novel method for isolating cardiomyocytes from an adult mouse heart without a Langendorff apparatus was developed. This epoch-making method was based on the antegrade perfusion of the coronary arteries9. We recently improved each step of this antegrade protocol, such as the clamping of the aorta, needle insertion, and temperature control, and monitored all perfusion procedures with a microscope10. We herein report in detail the refinement of this antegrade perfusion method to shorten the time for isolation and provide a supplemental video. In this method, the perfusion of the heart takes approximately 7 min with 10 mL of the enzymes, and this short digestion period increases the viability of the cells. This is a simple method for isolating single heart cells at a high quality without requiring the addition of chemicals, such as 2,3-butanedione monoxime (BDM)6,11 or taurine5,8. We believe that this method will lower the skill threshold of the technique and enhance the utility of mouse cardiomyocytes in basic research.

<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td>Amphotericin B</td>
			<td>Wako Pure Chemical Industries, Japan</td>
			<td></td>
			<td></td>
		</tr>
		<tr>
			<td>Alexa Fluor 488 anti-mouse IgG antibody</td>
			<td>Molecular Probes, USA</td>
			<td>A11001</td>
			<td>Fluorescent-labeled secondary antibody. (1:400 dilution for immunostaining)</td>
		</tr>
		<tr>
			<td>Anti-&#945;-actinin (ACTN)</td>
			<td>Sigma-Aldrich, USA</td>
			<td>A7811</td>
			<td>Mouse monoclonal antibody (clone EA-53). (1:400 dilution for immunostaining)</td>
		</tr>
		<tr>
			<td>Anti-atrial natriuretic peptide (ANP)</td>
			<td>Merck-Millipore, USA</td>
			<td>AB5490-I</td>
			<td>Rabbit polyclonal antibody (1:2000 dilution for Western blots)</td>
		</tr>
		<tr>
			<td>Anti-Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)</td>
			<td>Cell Signaling Technology, USA</td>
			<td>2118</td>
			<td>Mouse monoclonal antibody (1:10000 dilution for Western blots)</td>
		</tr>
		<tr>
			<td>Anti-smooth muscle actin (SMA)</td>
			<td>Dako, Denmark</td>
			<td>M0851</td>
			<td>Mouse monoclonal antibody (clone 1A4) (1:400 for immunostaining)</td>
		</tr>
		<tr>
			<td>Anti-rabbit IgG antibody</td>
			<td>Amersham, GE Healthcare, USA</td>
			<td>NA934</td>
			<td>Secondary antibody (1:10000 dilution for Western blots)</td>
		</tr>
		<tr>
			<td>ATP disodium salt</td>
			<td>Sigma-Aldrich, USA</td>
			<td>A26209</td>
			<td></td>
		</tr>
		<tr>
			<td>Bovine serum albumin (BSA)</td>
			<td>Sigma-Aldrich, USA</td>
			<td>A9418</td>
			<td></td>
		</tr>
		<tr>
			<td>Cell-Tak</td>
			<td>Corning</td>
			<td>354240</td>
			<td>Biological material for adhesion of the cell or tissues</td>
		</tr>
		<tr>
			<td>Chemi-Lumi One Super&#160;</td>
			<td>Nacalai Tesque, Japan</td>
			<td>02230-14</td>
			<td>Chemiluminescent reagent used for western blotting.</td>
		</tr>
		<tr>
			<td>Collagenase Type 2</td>
			<td>Worthington Biochemicals, USA</td>
			<td>LS004176</td>
			<td>Choose the activity guaranteed to be greater than 300 unit/mg.</td>
		</tr>
		<tr>
			<td>Complete Mini</td>
			<td>Roche, Germany</td>
			<td>11836153001</td>
			<td>A mixture of several protease inhibitors.</td>
		</tr>
		<tr>
			<td>4&#39;6&#39;diamidino-2-phenylindole (DAPI)</td>
			<td>Nacalai Tesque, Japan</td>
			<td>11034-56</td>
			<td>Used for cell-impermeant nuclear stainig&#160;</td>
		</tr>
		<tr>
			<td>Dulbecco&#39;s Modified Eagle&#39;s Medium (DMEM)</td>
			<td>Nacalai Tesque, Japan</td>
			<td>08458-45</td>
			<td>including 4.5 g/L gluose</td>
		</tr>
		<tr>
			<td>Extension tube</td>
			<td>Top, Japan</td>
			<td>X1-50</td>
			<td>Connect with syringe and injection needle for antegrade perfusion.&#160;</td>
		</tr>
		<tr>
			<td>EPC-8 patch-clamp amplifier</td>
			<td>HEKA, Germany</td>
			<td></td>
			<td></td>
		</tr>
		<tr>
			<td>Fetal bovine serum (FBS)</td>
			<td>Sigma-Aldrich, USA</td>
			<td>F7524-500ML</td>
			<td></td>
		</tr>
		<tr>
			<td>Glass capillaries</td>
			<td>Narishige Scientific Instrument Lab., Japan</td>
			<td></td>
			<td>outside diameter 1.5 mm, inside diameter 0.9 mm</td>
		</tr>
		<tr>
			<td>GTP lithium salt</td>
			<td>Sigma-Aldrich, USA</td>
			<td>G5884</td>
			<td></td>
		</tr>
		<tr>
			<td>Horizontal microelectrode puller&#160;</td>
			<td>Germany)</td>
			<td>P-97</td>
			<td></td>
		</tr>
		<tr>
			<td>Heater mat</td>
			<td>Natsume Seisakusho, Japan</td>
			<td>KN-475-3-40</td>
			<td>Equipment to warm the perfusion plate.</td>
		</tr>
		<tr>
			<td>Infusion pump</td>
			<td>TERUMO, Japan</td>
			<td>TE-311</td>
			<td>Infusion syringe pump for antegrade perfusion.</td>
		</tr>
		<tr>
			<td>Injeciton needle (27 gauge)</td>
			<td>TERUMO, Japan</td>
			<td>NN-2719S</td>
			<td>Needle for insertion into the left ventricle.</td>
		</tr>
		<tr>
			<td>Insulin (from bovine pancrease)</td>
			<td>Sigma-Aldrich, USA</td>
			<td>I5500</td>
			<td>Dissolve in 0.1 M HCl.</td>
		</tr>
		<tr>
			<td>Mini cordless grinder</td>
			<td>Funakoshi, Japan</td>
			<td>cG-4A</td>
			<td>Small grinder for homogenizing tissue in 1.5 mL sample tube.</td>
		</tr>
		<tr>
			<td>4%-Paraformaldehyde Phosphate Buffer solution (4% PFA)</td>
			<td>Nacalai Tesque, Japan</td>
			<td>09154-85</td>
			<td></td>
		</tr>
		<tr>
			<td>Penicillin G potassium</td>
			<td>Nacalai Tesque, Japan</td>
			<td>26239-84</td>
			<td></td>
		</tr>
		<tr>
			<td>Phenol Red</td>
			<td>Nacalai Tesque, Japan</td>
			<td>26807-21</td>
			<td></td>
		</tr>
		<tr>
			<td>10X Phosphate Buffered Saline (pH7.4) (10X PBS)</td>
			<td>Nacalai Tesque, Japan</td>
			<td>27575-31</td>
			<td></td>
		</tr>
		<tr>
			<td>Plastic multi-well culture plate</td>
			<td>Falcon, USA</td>
			<td>353226</td>
			<td>Use the lid of the multi-well culture plate as the perfusion plate.</td>
		</tr>
		<tr>
			<td>Plastic syringe (20 mL)</td>
			<td>TERUMO, Japan</td>
			<td>SS-20ES</td>
			<td>Use for infusion of CIB-EGTA.</td>
		</tr>
		<tr>
			<td>Plastic syringe (30 mL)</td>
			<td>TERUMO, Japan</td>
			<td>SS-30ES</td>
			<td>Use for infusion of Enzyme-mix</td>
		</tr>
		<tr>
			<td>Plastic transfer pipette</td>
			<td>Sarstedt, Germany</td>
			<td>86.1171</td>
			<td>Cut the tip just before sucking mouse heart into the pipette.</td>
		</tr>
		<tr>
			<td>Polyvinylidene difluoride (PVDF) membrane</td>
			<td>Merck-Millipore, USA</td>
			<td>IPVH00010</td>
			<td>Immobilin-P membrane (Transfer membrane for protein blotting)</td>
		</tr>
		<tr>
			<td>Protease</td>
			<td>Sigma-Aldrich, USA</td>
			<td>P5147</td>
			<td>A mixture of three or more proteases including extracellular serine protease.</td>
		</tr>
		<tr>
			<td>4X Sample buffer solution</td>
			<td>Fuji Film, Japan</td>
			<td>198-13282</td>
			<td>Contains 0.25 M Tris-HCl (pH 6.8), 8 w/v% SDS,40 w/v% Glyceroland 0.02 w/v% BPB</td>
		</tr>
		<tr>
			<td>SDS polyacrylamide gel&#160; (15%)</td>
			<td>Fuji Film, Japan</td>
			<td>193-14991</td>
			<td></td>
		</tr>
		<tr>
			<td>Streptomycin sulfate</td>
			<td>Nacalai Tesque, Japan</td>
			<td>32237-14</td>
			<td></td>
		</tr>
		<tr>
			<td>10X Tris-Glycine buffer solution (10X TG)</td>
			<td>Nacalai Tesque, Japan</td>
			<td>09422-81</td>
			<td>Contains 0.25 M-Tris and 1.92 M-Glycine, (pH 8.3)&#160;</td>
		</tr>
		<tr>
			<td>Trypsin</td>
			<td>Sigma-Aldrich, USA</td>
			<td>T8003</td>
			<td>Trypsin from bovine Type 1.&#160;</td>
		</tr>
		<tr>
			<td>Vascular clamp</td>
			<td>Karl Hammacher GmbH, Germany</td>
			<td>HSE 004-35</td>
			<td>Small straight vascular clamp used for clamping aorta.</td>
		</tr>
		<tr>
			<td>All other reagents</td>
			<td>Nacalai Tesque, Japan</td>
			<td></td>
			<td></td>
		</tr>
	</tbody>
</table>

an antegrade perfusion method for cardiomyocyte isolation from mice

In basic research using mouse heart, isolating viable individual cardiomyocytes is a crucial technical step to overcome. Traditionally, isolating cardiomyocytes from rabbits, guinea pigs or rats has been performed via retrograde perfusion of the heart with enzymes using a Langendorff apparatus. However, a high degree of skill is required when this method is used with a small mouse heart. An antegrade perfusion method that does not use a Langendorff apparatus was recently reported for the isolation of mouse cardiomyocytes. We herein report a complete protocol for the improved antegrade perfusion of the excised heart to isolate individual heart cells from adult mice (8 - 108 weeks old). Antegrade perfusion is performed by injecting perfusate near the apex of the left ventricle of the excised heart, the aorta of which was clamped, using an infusion pump. All procedures are carried out on a pre-warmed heater mat under a microscope, which allows for the injection and perfusion processes to be monitored. The results suggest that ventricular and atrial myocytes, and fibroblasts can be well isolated from a single adult mouse simultaneously.

The principle of this method is simple: the perfusate flows from the left chamber, the aortic valve is opened, and the perfusate runs into the coronary artery in the same direction as the blood run, since the aorta is closed by clamping, which enables the deep perfusion of the myocardium in order to digest the extracellular matrix.
Ventricular myocytes freshly isolated with the present method are shown in Figure 1A. Figure 1B shows enlarged images of the ventricular and atrial myocytes. This isolation procedure resulted in a high yield (70%-80%) of rod-shaped quiescent ventricular myocytes from adult mice (8-10 weeks), which were available within roughly 5 h after isolation (Figure 1C), a similar interval to that when using the traditional Langendorff-based procedure7. However, the ratio of freshly isolated viable cells was lower in aged mice of &#62;2 years old (Figure 1C). The total number of ventricular myocytes obtained per adult heart using this protocol was approximately 3 x 106 cells, which was similar to the value previously reported7,12. The action potentials recorded in the ventricular and atrial myocytes (Figure 1D) were similar to those in cells obtained by the Langendorff-based method10. An immunostaining analysis confirmed that the sarcomeric structure of the ventricular myocytes was well-organized with a clearly visible cell membrane (Figure 2A). The individual cardiomyocytes isolated with this method can be directly used in experiments, such as an electrophysiological analysis10 or immunostaining experiment.
Cardiac fibroblasts exist in interstitial spaces. Sufficient digestion of the extracellular matrix results in the isolation of those cells. The isolated cardiac fibroblasts proliferate under culture conditions and can be passaged several times or stored in liquid nitrogen in an appropriate cell reservoir solution. Figure 2B shows that most of the cultured cardiac fibroblasts had transformed into myofibroblasts during subculture, as confirmed by the increased expression of &#945;-smooth muscle actin13,14. Also, the cardiac progenitors can be isolated with the present method and cultured in appropriate culture medium, which start beating automatically10,15.
Homogenization of the robust myocardium is not easy, especially for cardiac tissue from aged mice, which possesses a large amount of extracellular fibers. After antegrade perfusion, protein from the atria and ventricles can be easily homogenized in the lysis buffer with light force to extract proteins. A Western blot analysis demonstrated the specific expression of ANP in atria but not in ventricles from adult (20 weeks old) and aged (108 weeks old) mice (Figure 3).
<img alt="Figure 1" class="xfigimg" src="/files/ftp_upload/61866/61866fig1.jpg" /> 
Figure&#160;1. Isolated cardiomyocytes from mice.&#160;A. Ventricular myocytes freshly isolated with the antegrade perfusion, with images acquired with low magnification. After the final washing, the cardiomyocytes were resuspended with 2 mL of cell resuspension solution, 100 &#181;L of which was dropped onto the glass-bottom culture dish and cell settlement awaited. Bar, 100 &#181;m. B. Enlarged images of isolated ventricular myocytes (upper) and atrial myocytes (lower). Bar, 100 &#181;m. C. Isolated cells were suspended in the cell resuspension solution and stored at 37&#176;C for the desired period, and the number of live ventricular myocytes was counted in 10-15 fields under a microscope. Rounded cells were considered to have been irreversibly injured or dead16. Green, blue and red symbols were obtained from 3 mice at 8-10 weeks old, and black symbols were from 106 weeks old mouse. Yellow symbol indicates the mean of each group. D. Representative action potentials recorded from ventricular (black) and atrial (red) myocytes of 8-10 mice. The data were obtained from the cells approximately 3 h after isolation. <a href="https://www.jove.com/files/ftp_upload/61866/61866fig1large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 2" class="xfigimg" src="/files/ftp_upload/61866/61866fig2.jpg" /> 
Figure&#160;2. Immunostaining for &#945;-actinin in isolated mouse ventricular myocytes and &#945;-smooth muscle actin in cultured mouse cardiac fibroblasts.&#160;A. Confocal laser scanning microscopy of immunostaining for &#945;-actinin (green), DAPI staining for nuclei (blue) and a DIC image of ventricular myocytes isolated from mouse heart with antegrade perfusion. Bar, 50 &#181;m. B. Immunostaining for &#945;-smooth muscle actin (green), DAPI staining for nuclei (blue) and a DIC image of cardiac fibroblasts isolated from mouse heart with antegrade perfusion. Cardiac fibroblasts were cultured for four days. Bar, 100 &#181;m. <a href="https://www.jove.com/files/ftp_upload/61866/61866fig2large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<img alt="Figure 3" class="xfigimg" src="/files/ftp_upload/61866/61866fig3.jpg" /> 
Figure&#160;3. Western blot analyses of ANP in atria and ventricles.&#160;Western blot analyses for the atrial marker atrial natriuretic peptide (ANP) in atria (A) and ventricles (V) prepared from adult (20 weeks) and aged (108 weeks) hearts. ANP is present in the atria but absent in the ventricles. Use glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as a control house-keeping protein. <a href="https://www.jove.com/files/ftp_upload/61866/61866fig3large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td colspan="2">Stock solutions for isolating heart cells</td>
		</tr>
		<tr>
			<td colspan="2">10X CIB (500 mL)</td>
		</tr>
		<tr>
			<td>NaCl</td>
			<td>37.99 g</td>
		</tr>
		<tr>
			<td>KCI</td>
			<td>2.01 g</td>
		</tr>
		<tr>
			<td>1 M MgCl2</td>
			<td>2.5 mL</td>
		</tr>
		<tr>
			<td>NaH2PO4</td>
			<td>0.23 g</td>
		</tr>
		<tr>
			<td>HEPES&#160;</td>
			<td>29.79 g</td>
		</tr>
		<tr>
			<td>DW</td>
			<td>Fill up to 500 mL</td>
		</tr>
		<tr>
			<td colspan="2">100 mM CaCl2 stock soution</td>
		</tr>
		<tr>
			<td>CaCl2&#160;</td>
			<td>100 mM</td>
		</tr>
		<tr>
			<td colspan="2">400 mM EGTA stock solution</td>
		</tr>
		<tr>
			<td>EGTA</td>
			<td>400 mM</td>
		</tr>
		<tr>
			<td colspan="2">Insulin solution</td>
		</tr>
		<tr>
			<td>Insulin</td>
			<td>1 unit/mL in 0.1 M HCl</td>
		</tr>
		<tr>
			<td colspan="2">50X Antibiotics stock solution (20 mL)</td>
		</tr>
		<tr>
			<td>Penicillin</td>
			<td>100 mg</td>
		</tr>
		<tr>
			<td>Streptomycin</td>
			<td>100 mg</td>
		</tr>
		<tr>
			<td>Phenol red</td>
			<td>1.5 g</td>
		</tr>
		<tr>
			<td>DW</td>
			<td>20 mL and sterilize with filtering</td>
		</tr>
		<tr>
			<td colspan="2">10X Tyrode solution (1000 mL)</td>
		</tr>
		<tr>
			<td>NaCl</td>
			<td>81.82 g</td>
		</tr>
		<tr>
			<td>KCl</td>
			<td>4.03 g</td>
		</tr>
		<tr>
			<td>1 M MgCl2</td>
			<td>5 mL</td>
		</tr>
		<tr>
			<td>NaH2PO4</td>
			<td>0.47 g</td>
		</tr>
		<tr>
			<td>HEPES&#160;</td>
			<td>11.92 g</td>
		</tr>
		<tr>
			<td>NaOH</td>
			<td>0.8 g</td>
		</tr>
		<tr>
			<td>DW</td>
			<td>Fill up to 1000 mL</td>
		</tr>
		<tr>
			<td colspan="2">Stock solutin for immunostaining</td>
		</tr>
		<tr>
			<td colspan="2">DAPI stock</td>
		</tr>
		<tr>
			<td>DAPI</td>
			<td>2 mg/mL in methanol</td>
		</tr>
		<tr>
			<td colspan="2">Stock solutions for Western blots</td>
		</tr>
		<tr>
			<td colspan="2">&#160;HEPES buffer (100 mL)</td>
		</tr>
		<tr>
			<td>NaCl</td>
			<td>0.88 g</td>
		</tr>
		<tr>
			<td>400 mM EGTA</td>
			<td>0.25 mL</td>
		</tr>
		<tr>
			<td>HEPES&#160;</td>
			<td>0.24 g</td>
		</tr>
		<tr>
			<td>1M NaOH</td>
			<td>adjust pH to 7.4</td>
		</tr>
		<tr>
			<td>DW</td>
			<td>Fill up to 500 mL</td>
		</tr>
		<tr>
			<td colspan="2">Protease inhibitors cocktail&#160;</td>
		</tr>
		<tr>
			<td>Complete mini</td>
			<td>1 tablet</td>
		</tr>
		<tr>
			<td>DW</td>
			<td>0.4 mL</td>
		</tr>
	</tbody>
</table>
Table 1. Description of the stock solutions.&#160;Keep stock solutions at 4 &#176;C. Aliquot protease inhibitors cocktail for storage at -20 &#176;C.
<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td colspan="2">Solutions for isoltaing heart cells</td>
		</tr>
		<tr>
			<td colspan="2">CIB (200 mL)</td>
		</tr>
		<tr>
			<td>10X CIB</td>
			<td>20 mL</td>
		</tr>
		<tr>
			<td>Insulin solution</td>
			<td>0.01 mL</td>
		</tr>
		<tr>
			<td>Glucose</td>
			<td>0.79 g</td>
		</tr>
		<tr>
			<td>1M NaOH</td>
			<td>pH adjust to 7.4</td>
		</tr>
		<tr>
			<td>DW</td>
			<td>Fill up to 200 mL</td>
		</tr>
		<tr>
			<td colspan="2">Enzyme-mix solution (30 mL)</td>
		</tr>
		<tr>
			<td>Collagenase type2</td>
			<td>30 mg</td>
		</tr>
		<tr>
			<td>Trypsin</td>
			<td>1.8 mg</td>
		</tr>
		<tr>
			<td>Protease</td>
			<td>1.8 mg</td>
		</tr>
		<tr>
			<td>100 mM CaCl2 stock solution</td>
			<td>0.09 mL</td>
		</tr>
		<tr>
			<td>CIB</td>
			<td>30 mL</td>
		</tr>
		<tr>
			<td colspan="2">CIB-Ca2+-BSA (15 mL)</td>
		</tr>
		<tr>
			<td>BSA</td>
			<td>30 mg</td>
		</tr>
		<tr>
			<td>100 mM CaCl2 stock solution</td>
			<td>0.18 mL</td>
		</tr>
		<tr>
			<td>CIB</td>
			<td>15 mL</td>
		</tr>
		<tr>
			<td colspan="2">CIB-EGTA (150 mL)</td>
		</tr>
		<tr>
			<td>400 mM EGTA stock solution</td>
			<td>0.150 mL</td>
		</tr>
		<tr>
			<td>CIB</td>
			<td>150 mL</td>
		</tr>
		<tr>
			<td colspan="2">Tyrode solution (1000 mL)</td>
		</tr>
		<tr>
			<td>10X Tyrode stock solution</td>
			<td>100 mL</td>
		</tr>
		<tr>
			<td>Glucose&#160;</td>
			<td>0.99 g</td>
		</tr>
		<tr>
			<td>1M CaCl2</td>
			<td>1.8 mL</td>
		</tr>
		<tr>
			<td>1M NaOH</td>
			<td>pH adjust to 7.4</td>
		</tr>
		<tr>
			<td>DW</td>
			<td>Fill up to 1000&#160; mL</td>
		</tr>
		<tr>
			<td colspan="2">Cell resuspension solution (15 mL)</td>
		</tr>
		<tr>
			<td>BSA</td>
			<td>30 mg</td>
		</tr>
		<tr>
			<td>50X Antibiotics stock solution</td>
			<td>0.3 mL</td>
		</tr>
		<tr>
			<td>Tyrode solution</td>
			<td>15 mL</td>
		</tr>
		<tr>
			<td colspan="2">Solutions for immunostaining</td>
		</tr>
		<tr>
			<td colspan="2">Cell adherent solution (0.3 mL)</td>
		</tr>
		<tr>
			<td>Cell-Tak</td>
			<td>0.01 mL</td>
		</tr>
		<tr>
			<td>0.1 M NaHCO3 (pH8.0)</td>
			<td>0.285 mL</td>
		</tr>
		<tr>
			<td>0.1 M NaOH</td>
			<td>0.005 mL</td>
		</tr>
		<tr>
			<td colspan="2">Blocking-permeabilizatin solution (10 mL)</td>
		</tr>
		<tr>
			<td>Fetal bovine serum</td>
			<td>1 mL</td>
		</tr>
		<tr>
			<td>Triton X-100</td>
			<td>1 mL</td>
		</tr>
		<tr>
			<td>10X PBS</td>
			<td>1 mL</td>
		</tr>
		<tr>
			<td>DW</td>
			<td>7 mL</td>
		</tr>
		<tr>
			<td colspan="2">K+ rich pipette solution</td>
		</tr>
		<tr>
			<td>Potassium aspartate</td>
			<td>70 mM</td>
		</tr>
		<tr>
			<td>KCl</td>
			<td>50 mM</td>
		</tr>
		<tr>
			<td>KH2PO4</td>
			<td>10 mM</td>
		</tr>
		<tr>
			<td>MgSO4</td>
			<td>1 mM</td>
		</tr>
		<tr>
			<td>ATP disodium salt</td>
			<td>3 mM</td>
		</tr>
		<tr>
			<td>GTP lithium salt</td>
			<td>0.1 mM</td>
		</tr>
		<tr>
			<td>EGTA</td>
			<td>5 mM</td>
		</tr>
		<tr>
			<td>HEPES</td>
			<td>5 mM</td>
		</tr>
		<tr>
			<td>KOH</td>
			<td>pH adjust to 7.2</td>
		</tr>
		<tr>
			<td colspan="2">Solutions for Western blots</td>
		</tr>
		<tr>
			<td colspan="2">Lysis buffer (1 mL)</td>
		</tr>
		<tr>
			<td>HEPES buffer</td>
			<td>0.86 mL</td>
		</tr>
		<tr>
			<td>Nonidet-P40</td>
			<td>0.1 mL</td>
		</tr>
		<tr>
			<td>Protease inhibitors cocktail</td>
			<td>0.04 mL</td>
		</tr>
		<tr>
			<td colspan="2">Runnning buffer (1000 mL)</td>
		</tr>
		<tr>
			<td>10X TG (0.25 M Tris and 1.92 M Glycine)</td>
			<td>100 mL</td>
		</tr>
		<tr>
			<td>SDS</td>
			<td>1 g</td>
		</tr>
		<tr>
			<td>DW</td>
			<td>900 mL</td>
		</tr>
		<tr>
			<td colspan="2">Transfer buffer (1000 mL)</td>
		</tr>
		<tr>
			<td>10X TG</td>
			<td>100 mL</td>
		</tr>
		<tr>
			<td>Methanol</td>
			<td>200 mL</td>
		</tr>
		<tr>
			<td>DW</td>
			<td>700 mL</td>
		</tr>
		<tr>
			<td colspan="2">Blotting buffer (TBST)&#160; (1000 mL)</td>
		</tr>
		<tr>
			<td>5M NaCl</td>
			<td>20 mL</td>
		</tr>
		<tr>
			<td>2M Tris-HCl (pH 7.5)</td>
			<td>5 mL</td>
		</tr>
		<tr>
			<td>10% Tween 20</td>
			<td>10 mL</td>
		</tr>
		<tr>
			<td>DW</td>
			<td>965 mL</td>
		</tr>
	</tbody>
</table>
Table 2. Description of the working solutions for isolating heart cells, immunostaining and Western blotting.&#160;Prepare all working solutions just before the experiments.
Supplementary Figure&#160;1. Outline of the cell isolation.&#160;Flow diagram of the isolation of ventricular and atrial myocytes and cardiac fibroblasts from a single heart.&#160;<a href="https://www.jove.com/files/ftp_upload/61866/SupplementaryFig1R.pdf" target="_blank">Please click here to download this figure.</a>

Watch this Scientific Journal Video about An Antegrade Perfusion Method for Cardiomyocyte Isolation from Mice at JoVE.com

An Antegrade Perfusion Method for Cardiomyocyte Isolation from Mice

We developed a simple method for isolating high quality individual mouse heart cells by the antegrade perfusion technique. This method is Langendorff-free and useful for isolating ventricular and atrial myocytes or interstitial cells, such as cardiac fibroblasts or progenitors.

In basic research using mouse heart, isolating viable individual cardiomyocytes is a crucial technical step to overcome. Traditionally, isolating ...

We developed a simple Langendorff-free method for isolating individual mouse heart cells by an antegrade packaging technique. This method allows the isolation of heart cells from juvenile to older mice. Langendorff-based retrograde perfusion has been regarded as a gold standard for isolating cardiac myocytes in various experimental animals.However, cannulation of the LTA is technically difficult in mice due to their small size. For mouse heart harvest, after confirming euthanasia and shaving the abdomen, open the thoracic cavity quickly to expose the heart and use a plastic transfer pipette with the tip cut to approximately the size of the heart to suck the heart into the pipette. Raise the pipette to create enough space to insert curved scissors and use the scissors to excise the heart from the dorsal side taking care to avoid damaging the atria.Immediately, place the heart into a 30 milliliter glass beaker containing ice cold CIB-EGTA for about one minute. When the contractions have stopped, place the heart in a 35 milliliter culture dish containing ice cold CIB-EGTA, and remove the lung and other visible tissue. Place the roughly cleaned heart onto a heart stand filled with chilled CIB-EGTA apex side down and place the stand under a stereoscopic microscope.Remove the fat and connective tissues from around the aorta. If the length of the cut aorta is too long, trim the aorta just under the brachiocephalic artery and orient the heart so that the anterior surface is facing forward. Use tweezers to lift the end of the aorta and use a small vascular clamp to clamp the aorta near the atria while gently pushing down on the atria.Then place the clamped heart on a perfusion plate with the anterior side facing up and hydrate the heart with a few drops of CIB-EGTA. For antegrade perfusion, load a 20 milliliter syringe containing prewarmed CIB-EGTA connected to a flexible extension tube and a marked injection needle onto the infusion pump and start the pump at a 0.5 milliliter per minute flow rate. When the needle and pump have been filled, place the injection needle on the perfusion plate with the shorter side of the diagonal shape in front and slide the needle until it is just touching the apex of the heart.Carefully, insert the needle near the apex of the left ventricle into the ventricular chamber without twisting or detaching the needle from the plate, watching the mark to estimate the depth of the needle insertion. When the needle insertion is complete, blood should begin to flow from the coronary artery. Use tape to fix the injection needle to the plate and increase the pump speed to one milliliter per minute.If the heart is perfused successfully, the flow of the buffer in the capillary should be visible just under the epicardium. After two to three milliliters of CIB-EGTA perfusion, replace the perfusion buffer with enzyme mix. After one to two milliliters have been perfused, increase the pump speed to 1.5 milliliters per minute.Use a pipette to remove the accumulated blood-containing perfusate flowing from the heart as necessary and stop the perfusion when the total volume of perfused enzyme reaches 10 milliliters. At the end of the perfusion, transfer 10 milliliters of enzyme mix from the syringe to a 60 millimeter culture dish on a heater mat and add 20 milligrams of BSA to the dish. Gently swirl the dish to dissolve the powder and remove the injection needle and clamp from the heart.Remove the ventricles and atria from the heart and place the tissues into the BSA-supplemented enzyme mix. To isolate the ventricular myocytes, use two pairs of tweezers to grasp the epicardium and gently pull the ventricles into small pieces. When all of the ventricle fragments have been generated, disperse the cells approximately 30 times with gentle pipetting and filter the undigested debris through a 100 micron mesh cell strainer into a 15 milliliter centrifuge tube.After centrifugation, resuspend the cardiomyocyte pellet in prewarmed CIB supplemented with calcium and BSA and incubate the cells for five minutes at 37 degrees Celsius. At the end of the incubation, centrifuge the cells again and resuspend the precipitated cardiomyocytes in an appropriate volume of cell resuspension solution for their maintenance at 37 degrees Celsius until downstream analysis. To isolate the atrial myocytes, transfer the atria to a container of prewarmed CIB supplemented with calcium and BSA and tear the atria into pieces as demonstrated.Use a 20 microliter pipette set to 10 microliters to disrupt the tissues by pipetting and collect the dissociated cells by centrifugation. Then resuspend the atrial cell in an appropriate volume of cell resuspension solution. In this image, freshly isolated ventricular myocytes can be observed.This isolation procedure results in a 70 to 80%yield of rod-shaped quiescent ventricular myocytes from eight to 10-week-old mice within roughly five hours of isolation. The ratio of freshly isolated viable cells is lower in mice greater than two years of age. The action potentials recorded in the ventricular and atrial myocytes are similar to those measured in cells obtained by the Langendorff-based method.Immunostaining analysis can be used to assess the organization of the sarcomeric structure of the ventricular myocytes and the transformation of the cardiac fibroblasts into myofibroblasts after subculture. Western blot analysis is recommended to determine the specific expression of proteins of interest in the atria and ventricles after processing. After perfusion with enzymes, proteins from the atria and ventricles can be easily homogenized in lysis buffer with light force for protein extraction.It is important to control the direction and the depths of the needle insertion. When inserting the needle into the left ventricle, take care not to pierce the ventricular septum or to penetrate the valve. You can change the composition of the perfusate depending on the purpose of the experiment.For example, an EGTA supplemented detergent can be used to make a cell-free scaffold of the heart.

an-antegrade-perfusion-method-for-cardiomyocyte-isolation-from-mice

An Antegrade Perfusion Method for Cardiomyocyte Isolation from Mice

In This Article

Abstract

Reprints and Permissions